Elevance Health (ELV) reported Q4 adjusted earnings Thursday of $3.84 per diluted share, down from $5.62 a year earlier.
Analysts surveyed by FactSet expected $3.81.
Total revenue for the quarter ended Dec. 31 was $45.44 billion, compared with $42.65 billion a year earlier.
Analysts surveyed by FactSet expected $44.92 billion.
For 2025, the company said it expects adjusted diluted EPS in the range of $34.15 to $34.85. A single analyst polled by FactSet expects $34.52.
Shares were up more than 4% in premarket activity.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。
沒有相關數據
如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”